AroCell AB Logo

AroCell AB

Develops and markets diagnostic tests for monitoring cancer and bacterial diseases.

AROC | ST

Overview

Corporate Details

ISIN(s):
SE0003883990
LEI:
549300RF3VQBLGOJ7J46
Country:
Sweden
Address:
Karlsbodavägen 39, 168 67 Bromma
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

IDL Diagnostics AB, formerly AroCell AB, is a Swedish diagnostics company that develops and markets in vitro diagnostic (IVD) tests to improve the monitoring of oncological and bacterial diseases. The company's product portfolio provides high-value clinical information for disease detection, diagnosis, and therapy response monitoring. Key products include UBC® Rapid, a point-of-care test for bladder cancer; TUBEX® TF, for the rapid detection of acute typhoid fever; and TK 210 ELISA, a biomarker for monitoring cell proliferation in various cancers. IDL Diagnostics aims to provide healthcare professionals with patient-friendly and cost-effective tools to support clinical decision-making.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all AroCell AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for AroCell AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Pluri Inc. Logo
Develops placenta-based cell therapeutics using a proprietary 3D cell-expansion platform.
Israel PLUR
A global supplier of generic APIs using AI to accelerate drug development.
South Korea 041910
Poltreg S.A. Logo
Pioneering T-regulatory cell therapies for autoimmune diseases like diabetes, MS, and ALS.
Poland PTG
PolyPeptide Group AG Logo
A global CDMO specializing in peptide and oligonucleotide APIs for pharma and biotech partners.
Switzerland PPGN
Develops sensitive point-of-care biomarker diagnostics for human and animal health.
South Korea 335810
A global CDEMO offering end-to-end solutions for antibody therapeutics and biologics.
South Korea 334970
Develops affordable biosimilars and novel antibody drugs for life-threatening diseases.
Singapore 950210
Develops protein-based immunotherapies for metabolic diseases, immune disorders, and cancer.
South Korea 296160
PROTEINA CO.,LTD. Logo
A biotech firm specializing in proteomics for drug discovery and diagnostics in oncology.
South Korea 468530
PROTIA INC. Logo
Develops IVD kits and instruments for allergy, POCT, infectious & autoimmune diseases.
South Korea 303360

Talk to a Data Expert

Have a question? We'll get back to you promptly.